Q2 2017 Earnings Estimate for Becton Dickinson and Co. Issued By Jefferies Group (BDX)
Becton Dickinson and Co. (NYSE:BDX) – Research analysts at Jefferies Group increased their Q2 2017 earnings per share estimates for shares of Becton Dickinson and in a research note issued on Thursday. Jefferies Group analyst B. Couillard now expects that the brokerage will post earnings per share of $2.39 for the quarter, up from their prior estimate of $2.31. Jefferies Group currently has a “Buy” rating on the stock. Jefferies Group also issued estimates for Becton Dickinson and’s Q1 2018 earnings at $2.31 EPS, Q2 2018 earnings at $2.63 EPS, Q3 2018 earnings at $2.77 EPS, Q4 2018 earnings at $2.74 EPS and FY2018 earnings at $10.45 EPS.
Becton Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.09 by $0.03. The business had revenue of $3.23 billion for the quarter, compared to the consensus estimate of $3.22 billion. Becton Dickinson and had a net margin of 7.82% and a return on equity of 24.44%. The company’s revenue was up 5.6% compared to the same quarter last year. During the same period last year, the firm posted $1.94 earnings per share.
A number of other equities analysts have also recently commented on BDX. Deutsche Bank AG reaffirmed a “buy” rating and issued a $189.00 target price (down from $197.00) on shares of Becton Dickinson and in a report on Friday, November 4th. Leerink Swann reaffirmed a “hold” rating on shares of Becton Dickinson and in a report on Tuesday, August 9th. Zacks Investment Research raised shares of Becton Dickinson and from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a report on Wednesday. Argus reaffirmed a “buy” rating and issued a $185.00 target price on shares of Becton Dickinson and in a report on Friday, October 21st. Finally, Cowen and Company reaffirmed an “outperform” rating and issued a $185.00 target price on shares of Becton Dickinson and in a report on Tuesday, August 16th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $175.39.
Becton Dickinson and (NYSE:BDX) opened at 170.36 on Friday. The stock has a market capitalization of $36.27 billion, a P/E ratio of 37.94 and a beta of 1.04. The stock has a 50 day moving average of $173.95 and a 200 day moving average of $171.84. Becton Dickinson and has a 1-year low of $129.50 and a 1-year high of $181.76.
Large investors have recently added to or reduced their stakes in the company. USA Financial Portformulas Corp purchased a new position in Becton Dickinson and during the third quarter worth about $2,909,000. Nomura Asset Management Co. Ltd. raised its position in Becton Dickinson and by 1.4% in the third quarter. Nomura Asset Management Co. Ltd. now owns 56,508 shares of the company’s stock worth $10,156,000 after buying an additional 790 shares during the period. ProShare Advisors LLC raised its position in Becton Dickinson and by 9.1% in the third quarter. ProShare Advisors LLC now owns 316,311 shares of the company’s stock worth $56,851,000 after buying an additional 26,432 shares during the period. Pathstone Family Office LLC raised its position in Becton Dickinson and by 0.4% in the third quarter. Pathstone Family Office LLC now owns 2,631 shares of the company’s stock worth $473,000 after buying an additional 10 shares during the period. Finally, Checchi Capital Advisers LLC raised its position in Becton Dickinson and by 7.5% in the third quarter. Checchi Capital Advisers LLC now owns 1,920 shares of the company’s stock worth $345,000 after buying an additional 134 shares during the period. Institutional investors and hedge funds own 82.30% of the company’s stock.
In related news, insider Stephen Sichak sold 10,352 shares of the business’s stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $176.10, for a total value of $1,822,987.20. Following the sale, the insider now directly owns 26,892 shares in the company, valued at approximately $4,735,681.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Linda M. Tharby sold 11,704 shares of the business’s stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the completion of the sale, the insider now owns 22,146 shares in the company, valued at $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.